The Korean market is becoming a top clinical trial destination due to its clear, stable regulatory structure with streamlined approval pathways that include short study start-up timelines (60 days).
Our new cGMP facility boasts a highly experienced local team supporting clinical research in South Korea.
The South Korean team is supported by our network of Asia Pacific facilities, including Singapore, Beijing & Suzhou in China, Japan and India, providing access to a global network with a local presence.
Download the site capabilities fact sheet to learn more about this location.
Incheon, Republic of Korea